IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 381 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $22,000 | +22.2% | 500 | 0.0% | 0.01% | +20.0% |
| Q2 2022 | $18,000 | -10.0% | 500 | -11.2% | 0.01% | 0.0% |
| Q1 2022 | $20,000 | +17.6% | 563 | 0.0% | 0.01% | +25.0% |
| Q4 2021 | $17,000 | +6.2% | 563 | +12.6% | 0.00% | 0.0% |
| Q3 2021 | $16,000 | -15.8% | 500 | 0.0% | 0.00% | -20.0% |
| Q2 2021 | $19,000 | -13.6% | 500 | 0.0% | 0.01% | -16.7% |
| Q1 2021 | $22,000 | -21.4% | 500 | 0.0% | 0.01% | -33.3% |
| Q4 2020 | $28,000 | +21.7% | 500 | 0.0% | 0.01% | +12.5% |
| Q3 2020 | $23,000 | -23.3% | 500 | 0.0% | 0.01% | -27.3% |
| Q2 2020 | $30,000 | +30.4% | 500 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $23,000 | -23.3% | 500 | 0.0% | 0.01% | +10.0% |
| Q4 2019 | $30,000 | +7.1% | 500 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $28,000 | -12.5% | 500 | 0.0% | 0.01% | -16.7% |
| Q2 2019 | $32,000 | – | 500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,136 | $133,749 | 7.12% |
| Bellevue Group AG | 9,743,900 | $368,027,103 | 4.88% |
| M28 Capital Management LP | 126,300 | $4,770,351 | 4.55% |
| Sicart Associates LLC | 246,258 | $9,301,165 | 3.28% |
| Camber Capital Management LP | 1,925,000 | $72,707 | 2.49% |
| Privium Fund Management B.V. | 148,807 | $5,557,941 | 2.11% |
| Deep Track Capital, LP | 1,205,773 | $45,542,046 | 1.91% |
| BVF INC/IL | 1,121,809 | $42,370,726 | 1.79% |
| Orbimed Advisors | 1,993,600 | $75,298,272 | 1.44% |
| Parkman Healthcare Partners LLC | 141,115 | $5,329,914 | 1.42% |